Views & Analysis Healthcare that no longer leaves out the patient For so long the US healthcare system was built around the provider, with appointments and services set by the provider (along with insurance reimbursement systems).
News Summit climbs on rumour of $15bn AstraZeneca interest Is AstraZeneca about to join the ranks of pharma companies spending big bucks on PD(L)-1xVEGF bispecific antibodies for cancer?
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face